Mageswary, Mageswaran Uma
Ang, Xin-Yee
Lee, Boon-Kiat
Chung, Yi-Li Fiona
Azhar, Siti Nur Afiqah
Hamid, Intan Juliana Abd
Bakar, Hafizi Abu
Roslan, Nurhanis Syazni
Liu, Xiaojun
Kang, Xiaohong
Dai, Lu
Sreenivasan, Sasidharan
Taib, Fahisham
Zhang, Heping
Liong, Min-Tze http://orcid.org/0000-0002-4471-8271
Clinical trials referenced in this document:
Documents that mention this clinical trial
Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study
https://doi.org/10.1007/s00394-021-02689-8
Funding for this research was provided by:
universiti sains malaysia (1001/PTEKIND/8070012)
Article History
Received: 9 July 2021
Accepted: 28 September 2021
First Online: 26 November 2021
Change Date: 5 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00394-022-02818-x
Declarations
:
: Xiaojun Liu is an employee of Beijing Scitop Biotech Co., Ltd.
: This study was conducted according to the guidelines laid down in the Declaration of Helsinki. All procedures involving human subjects were approved by the JEPeM-USM Review Panel on Clinical Studies (Approval No. USM/JEPeM/19030177) and was registered at ClinicalTrials.gov (identifier No. NCT04122495).
: Written informed consent has been obtained from all subjects to publish this paper.
Free to read: This content has been made available to all.